UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

UEG Week Berlin 2025 Recordings Gut Guide online What's new on Gutflix

Trending on Gutflix

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

HOW IS IT TO BE AN ENDOSCOPIC NURSE IN SWEDEN? A NATIONAL SURVEY INCLUDING 67 NURSES PERFORMING ENDOSCOPY

Fredrik Swahn 1, catharina wallenkampf 1

Affiliations

1 Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden

Summary

AI Generated

A Swedish survey of 67 endoscopy nurses shows that most find their professional role positive and rewarding after more than 20 years of practice, though one-third have experienced opposition and 60% report salary dissatisfaction.

Response rate was 96% (67/70 nurses); median age 50, median 5 years performing endoscopy, performing a median of 350 gastroscopies and 600 colonoscopies annually.
Doctors assess all referrals in 100% of cases; physician consultation during endoscopy is rare, usually provided within 2-5 minutes when needed for large polyps, cancer, or difficult bleeding, and doctors rarely take over procedures.
Almost all nurses (98%) appraise pathology results, and 62% are involved in endoscopic education and mentorship, with 80% of those teaching residents.
While 69% experience strong positive support from the medical team, 34% have felt opposed on various occasions, predominantly by doctors (82%) but also by other nurses (18%).
Median salary is approximately 4120 euros (range 2900-5870), which 60% of nurses find unsatisfactory, suggesting areas for professional improvement despite overall job satisfaction.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

There have been endoscopy nurses in Sweden for more than 2 decades. At least in the start, there were doubts and skepticism about their professional status. We wanted to investigate, by survey, how Swedish endoscopy nurses experience their professional role today.

Aims & Methods

A written questionnaire comprising 44 questions were sent to all registered (n=70) endoscopic nurses in. Sweden. The issues included: education, work load, medical responsibility, medical support, education of other professional categories, further education, research and salary.

Results

Responses were received by 67/70 (96%); 55F/12M; median age 50 [range 33-64]. Number of years in healthcare: median 25 years [range 10-45]. Number of years performing endoscopy: median 5 years [range 0,5-20]. Dedicated time for endoscopy: n=26 100%; n=20 70-99%; n=18 50-69%; n=3 20-49%. Annual number of gastroenteroscopy: median 350 [range 20-1400]; colonoscopy: median 600 [range 150-1500]. The doctors assess referrals in 100%. During endoscopy, consultation by physician is rare and support is usually provided within 2-5 minutes (90%) and is seldomly perceived as an inconvenience and the reason is usually related to large polyps, cancer and difficult bleeding. Taking over the endoscopic procedure by the doctor - happens rarely. Appraisal of PAD-results is performed by almost all nurses, n=66 (98%). Two-thirds n= 41 (62%) of nurses are involved in endoscopic education and mentorship, which of 80% include residents. One n=1 nurse has an ongoing doctorial project. A majority finds their professional role as positive, but n=23 (34%) have on various occasions felt opposed (82% by doctors; 18% by other nurses), however n=46 (69%) experiences strong positive support from the entire medical team. The median salary is approximately 4120 € [range 2900 – 5870] and n=40 (60%) find it not satisfactorily.

Conclusion

Endoscopy nurses in Sweden have over time been established as an important professional and educational contributor within endoscopy. The vast majority of endoscopic nurses find their job inspiring and rewarding, but there is still space for improvement.

Conference

UEG Week Copenhagen 2023

Submission format

Abstract

Session

PP 10 Health economics / Digitalisation in GI / Education In GI / Gender and diversity (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Matteo Tacelli 1, Alberta De monti 2, Maria Chiara Petrone 1, Piera Zaccari 1, Gemma Rossi 1, Francesco Prato 1, Diego Palumbo 1, Francesco De Cobelli 1, Paolo Giorgio Arcidiacono 1

Affiliations

1 San Raffaele Scientific Institute IRCCS, Milano, Italy

2 Lecco Hospital, Milano, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Fatty pancreas is an increasingly recognized condition associated with metabolic abnormalities, but its diagnosis remains poorly standardized. In clinical practice, endoscopic ultrasound (EUS) is widely used to assess pancreatic parenchyma, yet its interpretation is mainly qualitative and operator-dependent, while magnetic resonance imaging (MRI) currently represents the most reliable non-invasive reference standard for pancreatic fat quantification.

Aims & Methods

This study aimed to assess the agreement between expert EUS-based diagnosis of fatty pancreas and MRI, and to develop deep learning models for automated fatty pancreas detection on EUS images. A retrospective single-centre observational study was conducted at San Raffaele Hospital including consecutive patients who underwent diagnostic EUS between January 2023 and December 2025 and had abdominal MRI within 12 months. Fatty pancreas was defined on MRI by pancreatic fat fraction >6%. Agreement between EUS and MRI was assessed with Cohen’s kappa. Secondary analyses included operator-level performance and subgroup analyses. For the AI endpoint, convolutional neural network models were developed using three approaches: all available EUS images per patient, a single representative image per patient, and a segmentation-based strategy combined with an ensemble model.

Results

Among 2324 EUS procedures, 314 patients had MRI available and were included in the primary analysis; 150 had fatty pancreas and 164 did not. Patients with fatty pancreas were older than controls (65.8 ± 11.0 vs 58.7 ± 14.2 years, p<0.001), and dyslipidaemia was more frequent (41% vs 25%, p<0.001). Agreement between EUS and MRI was only fair (Cohen’s κ=0.31), with sensitivity 39.9%, specificity 91.5%, and overall accuracy 66.6%. Marked inter-operator variability was observed, with κ ranging from 0.06 to 0.82. Concordance tended to be higher in patients with BMI >25 kg/m² (κ=0.40 vs 0.20, p=0.05) and was significantly lower in chronic pancreatitis (κ=-0.16 vs 0.34, p=0.03). For deep learning, the model using all available images achieved an AUC of 0.70. The single-image model achieved an AUC of 0.713, with high sensitivity (0.86–0.95) but modest specificity (0.38–0.50). The best performance was obtained with the segmentation-based ensemble model, which reached an AUC of 0.724, accuracy 69.8%, sensitivity 90%, specificity 52%, and balanced accuracy 0.71 in the independent test set.

Conclusion

EUS shows limited agreement with MRI for fatty pancreas diagnosis and substantial inter-operator variability, supporting the need for more objective and standardized diagnostic criteria. Deep learning applied to EUS images demonstrated moderate discriminatory ability, with the segmentation-based ensemble approach providing the most promising results. These findings support further development of AI-assisted EUS tools to improve reproducibility and diagnostic performance in fatty pancreas assessment.

Event

UEG Week Barcelona 2026

Topics

Radiology & Imaging Hepatobiliary Endoscopy Pancreas

Submission format

Abstract

Session

Endoscopy: Taming the biliary tree

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Let’s not forget about TIPS: Improving outcomes in portal hypertension

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer 1

Affiliations

1 Medical University of Vienna, Vienna, Austria

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Mechanisms & Personalised Medicine Surgery Hepatobiliary

Session

How to manage cirrhosis in 2026

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Esther Toes-Zoutendijk 1, Lucie de Jonge 1, Emilie Breekveldt 1, Manon C.W. Spaander 1, Evelien Dekker 2, Folkert J. van Kemenade 1, Unknown Unknown 1, Iris Nagtegaal 3, Marc Thelen 4, Monique van leerdam 5, Iris Lansdorp-Vogelaar 6

Affiliations

1 Erasmus MC University Medical Center, Rotterdam, Netherlands

2 AMC, Amsterdam, Netherlands

3 Radboud University Nijmegen Medical Center Dept. of Pathology, Nijmegen, Netherlands

4 Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

5 Netherlands Cancer Institute, Amstelveen, Netherlands

6 Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Previous studies of fecal immunochemical test (FIT)-based colorectal cancer (CRC) screening programs have demonstrated that fecal hemoglobin (f-Hb) concentrations below the FIT positivity threshold, are associated with a higher risk of advanced neoplasia (AN) in subsequent screening rounds. These findings highlight the potential of risk-stratified CRC screening based on prior f-Hb concentrations. However, prospective evidence of this approach is lacking.

Aims & Methods

The aim of this randomized controlled trial (RCT) was to evaluate the of yield risk-tailored screening intervals based on prior f-Hb concentrations in a FIT-based CRC screening. The PERFECT‑FIT study (NCT05423886) recruited individuals aged 57 to 72 in 2022 and 2023 in the Netherlands. They were randomly assigned to either tailored screening intervals based on f-Hb concentrations measured in their prior negative FIT (1 year for >15 to <47 µg Hb/g feces, 2 years for >0 to ≤15 µg Hb/g feces, and 3 years for 0 µg Hb/g feces; intervention group) or the standard 2-year screening interval (control group). The primary outcome was the detection of AN (CRC and advanced adenomas) over one screening round.

Results

In total, 20,088 participants provided informed consent and were randomly assigned to either the control group (n = 10,211) or the intervention group (n=9,877). In the intervention group, 352 (3.6%) participants were assigned to a 1-year screening interval, 350 (3.5%) to a 2-year interval and 9,175 (92.9%) to a 3-year interval. 19,547 study participants returned their FIT (97.3%). The positivity rate of FIT was significantly higher in the intervention group (4.4%) than in the control group (3.7%; p=0.03). The detection rate of AN showed no significant difference between the intervention group (1.0%) and the control group (0.8%; p=0.21, Table 1). Within the intervention group, detection rate of AN for the extended 3-year interval (0.7%) was substantially lower than that of the 1-year (3.5%) and 2-year interval (5.0%). It was similar to that of the total control group, in which all individuals had received an uniform 2-year screening interval (Table 1).

Conclusion

In this nationwide RCT on risk-stratified CRC screening, the majority of individuals were classified as low risk based on undetectable f-Hb concentrations and were offered an extended screening interval. Risk-tailored screening intervals did not result in a higher detection rate of AN after one screening round for the total intervention group compared with the control arm. However, the yield among those assigned to an extended screening interval was comparable to that of the control group. These findings suggest that screening intervals can be safely extended for low-risk individuals, potentially improving screening efficiency without compromising screening yield.

Table 1: Detection rates of advanced neoplasia among participants in the control group and the intervention group in the PERFECT-FIT RCT, including the three intervention subgroups.

Group	Total participants	Advanced Neoplasia	Detection rate (%, 95%CI)	p value
Control	9963	79	0.8 (0.6-1.0)
Intervention	9584	93	1.0 (0.8-1.2)	0.21
1 year	347	12	3.5 (1.9-6.1)
2 year	341	17	5.0 (3.0-8.0)
3 year	8896	64	0.7 (0.6-0.9)

References

1. Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, Nieboer D, Ramakers CR, Spaander MCW, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Nagtegaal ID, Dekker E, van Leerdam ME, Lansdorp-Vogelaar I; Dutch colorectal cancer screening working group. Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model. Gut. 2023;72(1):101-108. doi: 10.1136/gutjnl-2022-327188.
2. van den Berg DMN, van den Puttelaar R, de Jonge L, Lansdorp-Vogelaar I, Toes-Zoutendijk E. Fecal Hemoglobin Levels in Prior Negative Screening and Detection of Colorectal Neoplasia: A Dose-Response Meta-Analysis. Gastroenterology. 2025;168(3):587-597. doi: 10.1053/j.gastro.2024.10.047.
3. Breekveldt ECH, Toes-Zoutendijk E, de Jonge L, Spaander MCW, Dekker E, van Kemenade FJ, van Vuuren AJ, Ramakers CRB, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). BMC Gastroenterol. 2023;23(1):45. doi: 10.1186/s12876-023-02670-1.

Disclosure

The authors have received research funding, unrelated to the present study, from Sentinel, Sysmex, Medtronic, and Norgine.

Event

UEG Week Barcelona 2026

Topics

Primary Care Oesophagus Hepatobiliary Endoscopy Digestive Oncology Colorectal

Submission format

Late-Breaking Abstract

Session

Late-Breaking: Advances in GI-endoscopy

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Yuya Asada 1, Minoru Kato 2, Reona Kawamura 3, Hideki Ishikawa 4, Takuya Okugawa 1, Mari Mizutani 5, Chika Fukuyama 6, Mari Nezu 7, Akiko Chino 6, Motohiko Kato 5, Masayoshi Yamada 3, Tomoki Michida 2, Shinichiro Shinzaki 1

Affiliations

1 Hyogo Medical University School of Medicine, Hyogo, Japan

2 Osaka International Cancer Institute, Osaka, Japan

3 National Cancer Center Hospital, Tokyo, Japan

4 Ishikawa Gastroenterology Clinic, Osaka, Japan

5 Keio University School of Medicine, Tokyo, Japan

6 Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

7 Hyogo Medical University, Hyogo, Japan

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Duodenal adenomatosis is common in familial adenomatous polyposis (FAP) and progression of the Spigelman stage (SS) predicts duodenal cancer risk [1, 2]. Evidence supporting institutional endoscopic treatment strategies, such as intensive downstaging polypectomy (IDP), remains limited[3, 4].

Aims & Methods

We evaluated whether an institutional IDP strategy is associated with reduced SS progression. This multicenter retrospective cohort study was conducted across five Japanese tertiary institutions. Patients with FAP who had duodenal lesions and underwent ≥2 esophagogastroduodenoscopies (EGDs) between 2016 and 2023 were included. Baseline EGD was defined as the first EGD performed in 2016 or later. IDP was defined as resection of ≥20 duodenal lesions during a single endoscopic session. Patients were classified into IDP (treated at institutions routinely performing IDP) or non-IDP groups. The primary endpoint was time to SS progression from baseline (≥1 SS increase, or SS IV to invasive cancer/surgery). Secondary exploratory endpoints included 3-year area under the SS (AUS), a time-integrated measure of cumulative disease severity, and subgroup analyses stratified by baseline SS.

Results

Among 586 patients assessed, 385 met the inclusion criteria (IDP n=308; non-IDP n=77). Median age was 40 years (interquartile range [IQR] 30–50) and 51% were women. Baseline SS: 0 7%, I 10%, II 34%, III 29%, IV 19%. Median follow-up was 67 months (IDP) vs 50 months (non-IDP). P). The 5-year progression rate was 17.4% in the IDP group and 42.2% in the non-IDP group. The cumulative incidence of SS progression was significantly lower in the IDP group than that in the non-IDP group (hazard ratio [HR], 0.33; 95% confidence interval [CI], 0.22–0.50). After adjustment for age, sex, and baseline SS (0–III vs IV), the results remained consistent (adjusted HR 0.38; 95% CI 0.26–0.58; p<0.001). The AUS was significantly smaller in the IDP group with baseline SS II and III (p=0.002 and p<0.001, respectively). Endoscopic treatment was performed in 197/308 (64% [IDP]) vs 25/77 (32% [non-IDP]); median number of resected lesions per patient was 61 (IQR, 11–226) vs 2 (IQR, 1–4). Endoscopic treatment-related adverse events occurred in 23/197 (12%) vs 2/25 (8%) (p=0.231): bleeding 7%, perforation 2%, pancreatitis 2% overall. No treatment-related deaths occurred.

Table. Key outcomes by institutional strategy (IDP vs non-IDP)

Outcome	IDP (n=308)	Non-IDP (n=77)
Spigelman stage progression, n (%)	58 (19)	41 (53)
5-year cumulative progression	17.4%	42.2%
Progression risk	HR 0.33 (95% CI, 0.22–0.55)	Reference
Resected lesions per patient, median [IQR]	61 [11–226]	2 [1–4]
Treatment-related adverse events, n (%)^*	23/197 (12)	2/25 (8)

IDP, intensive downstaging polypectomy; HR, hazard ratio; IQR, interquartile range
* p=0.231 for adverse events (IDP vs non-IDP). Adverse events comprised bleeding, perforation, and pancreatitis.

Conclusion

Institutional endoscopic management that routinely incorporate IDP were associated with a lower risk of SS progression. Prospective studies are warranted to confirm whether proactive lesion-reducing strategies improve long-term outcomes in FAP-associated duodenal disease.

References

1. Spigelman, A.D., et al., Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet, 1989. 2(8666): p. 783-5.
2. Bülow, S., et al., Duodenal adenomatosis in familial adenomatous polyposis. Gut, 2004. 53(3): p. 381-6.
3. Takeuchi, Y., et al., Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study. Endoscopy, 2023. 55(6): p. 515-523.
4. Iwata, K., et al., Intensive endoscopic resection strategy for multiple duodenal polyposis associated with familial adenomatous polyposis. J Gastroenterol Hepatol, 2023. 38(9): p. 1592-1597.

Event

UEG Week Barcelona 2026

Topics

Small Intestine & Nutrition Endoscopy Oesophagus

Submission format

Abstract

Session

Small intestine diseases: Inside the black box

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski 1

Affiliations

1 Catholic University of Rome Digestive Endoscopy Unit, Rome, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Surgery Mechanisms & Personalised Medicine Endoscopy

Session

A 360° multidisciplinary approach to obesity and metabolic health

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Drug-induced liver injury: new treatment strategies

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Drug-induced liver injury: new treatment strategies

Edmond Atallah 1

Affiliations

1 NIHR Nottingham Biomedical Research Centre & Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Mechanisms & Personalised Medicine Hepatobiliary

Session

What’s new in… Hepatitis and liver failure

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

DEEP LEARNING-BASED ENDOSCOPIC ULTRASOUND DIAGNOSIS OF FATTY PANCREAS: AGREEMENT WITH MRI AND PERFORMANCE OF AI MODELS

Paolo Giorgio Arcidiacono

Let’s not forget about TIPS: Improving outcomes in portal hypertension

Mattias Mandorfer

EFFECTIVENESS OF TAILORED SCREENING INTERVALS BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION IN FIT-BASED COLORECTAL CANCER SCREENING: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL PERFECT-FIT

Iris Lansdorp-Vogelaar

INSTITUTIONAL ENDOSCOPIC MANAGEMENT INCORPORATING INTENSIVE DOWNSTAGING POLYPECTOMY IS ASSOCIATED WITH REDUCED DUODENAL DISEASE PROGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS

Shinichiro Shinzaki

Beyond surgery: The expanding role of bariatric and metabolic endoscopy

Ivo Boskoski

Drug-induced liver injury: new treatment strategies

Edmond Atallah